Skip to main content
. 2020 Jan 28;25(3):565. doi: 10.3390/molecules25030565

Table 4.

Antimalarial and antimicrobial activities of selected fractions (percent inhibition).

DT (min) a P. falciparum D6 b C. neoformans b C. albicans b E. coli
1.0–2.5 39 0 10 4
10–30 16 9 9 8
120–240 14 55 11 6
0–240 18 0 6 0

No recorded inhibition observed for these tested fractions against A. fumigates, methicillin resistant Staphylococcus aureus (MRSA), P. aeruginosa, K. pneumonia, and vancomycin resistant Enterococci (VRE). a Test concentration of 16 ug/mL. b Test concentration of 200 ug/mL.